The prevalence of Graves' disease i...

The prevalence of Graves' disease in the United Kingdom is estimated at 1 to 27 percent of the population, and notice complications occur in one fourth to individual half of cases. Changes in the judgments may develop before the first brunt of Graves' disease, and occasionally solitary one eye is involved. Although it rarely causes vision los thyroid vigilance disease can be painful and distressing with significant visual and cosmetic sequelae. Cawood and colleagues examined the clinical features of thyroid estimate disease to clarify the pathophysiology of the condition and potential treatments.

Histologically, circulating sensitized orbital tissue-specific T lymphocyte and a local inflammatory cellular infiltrate are current in thyroid eye disease. The orbital fibroblasts appear guide to the hypertrophy of adipose tissue and accumulation of glycosaminoglycans in the orbit. Despite new research, the pathophysiology of Graves' disease remains unclear.

The clinical features of thyroid watch disease include ocular pain, photophobia, chemosis, diplopia, exophthalmos, and sight irritation ("gritty eyes"). Physical signs include proptosis, edema of the eyelid and conjunctiva, and diplopia (Table 1) The NO SPEC mnemonic frequently is used as a scoring hypothesis for severity of eye change (Table 2) Patients who disentangle blurred vision, reduced visual acuity or color perception, pupillary signs, or visual field foibles may have optic neuropathy and must be referr to an ophthalmologist immediately. The clinical features of thyroid sight disease may persist after the phase of acute inflammation because of residual scarring of orbital tissues. Thyroid organ of vision disease also may be accompanied by way of skin changes in the lower leg (pretibial myxedema), finger nails (acropachy), and at sites of previous skin trauma.

Smoking appears to be a major risk factor in developing estimate symptoms in Graves' disease, because patients with judgment involvement are four times more likely to be smoker than never-smoker The risk also is associated with the number of cigarettes smok for day. Other risk factors for thyroid notice disease are less well established. Older men may have a higher risk of more strict disease. Radioiodine therapy may cause a flare-up of vigilance disease.

Full ophthalmic assessment including comput tomography or magnetic resonance imaging can indicate the standing of involvement of the extraocular muscles and plastic tissues. Orbital biopsy is required occasionally to establish the diagnosis.

In mild cases, no other than symptomatic care to protect the views from drying is required. Up to 35 percent of patients require high-dose steroids or orbital decompression therapy. The rejoinder rates to steroid therapy range from 33 to 66 percent The dosage and regimen are individualized because no large randomized placebo-controlled trials have been mode of actioned Orbital radiotherapy also has been hinted for reducing progression of thyroid notice disease, but clinical trials have not demonstrated improvements, and adverse powers include cataracts, retinopathy, and risk of malignancy. Surgical decompression is indicated for morose cases during the acute phase and to improve function and appearance in later stages of the condition. Overall, issues of all treatments for thyroid sight disease are disappointing. More than single half of patients report persistent diplopia, about the same third are dissatisfied with the cosmetic accrue and more than one fourth have grave visual acuity.

Potential futurity treatments include anticytokine therapy, particularly anti-tumor necrosis factor-alpha agents. Side imports limit use of these agents. Octreotide and colchicine have given disappointing proceeds in recent clinical trials. [NOTE: Colchicine is no longer available in the United States.] The authors infer that increased understanding of thyroid organ of vision disease will likely lead to improvement of treatments in the future

Cawood T et al. modern developments in thyroid eye disease. BMJ August 14 2004;329:385-90

COPYRIGHT 2005 American Academy of Family Physicians

COPYRIGHT 2005 Gale Group